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Abstract: Screening strategies based on the ecological knowledge of antibiotic producing 
microorganisms and their roles in the natural environment are being increasingly employed 
in the search for novel antibiotic agents. Micromonosporae are common inhabitants of 
aquatic habitats and have proved to be a continuing source of novel bioactive compounds 
including antibacterial and antitumor agents. The ecological distribution and frequency of 
bioactive micromonosporae in Sunshine Coast region aquatic habitats were studied 
through a range of selective isolation procedures designed to negatively select against the 
isolation of unwanted microbial taxa commonly associated with marine environments. It 
was revealed that bioactive compound producing species of micromonosporae were 
present in the aquatic habitats of the Sunshine Coast region in Australia. 
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Introduction  
 
The search for novel therapeutic agents for use in the pharmaceutical industry is driven by the need 
to combat the increase in the incidence of infection due to antibiotic resistant pathogens coupled with 
the search for novel antitumor and antiviral compounds [3, 20]. Natural products have been the major 
source of numerous therapeutic agents [16, 25] producing more than a half of the drugs in use today in 
many therapeutic categories [7]. 
Biotechnology companies have been engaged in natural product discovery using “ecological” or 
“bio-rational” approaches to detect specialized genes and metabolites that enable the survival of Mar. Drugs 2008, 6                 
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producing organisms in diverse and extreme environments [18, 46, 52]. For example, genome scanning 
of the deep-sea actinomycete ‘Verrucosispora maris” has produced an estimate of >20 biosynthetic 
gene clusters in this organism [13]. Highly selective isolation methods are also being used as part of 
objective but less conservative approaches undertaken towards the detection of bioactive compound 
producing taxa [26, 38, 48, 55, 67] given that successful discovery of novel bioactive compounds or 
chemical structures rests significantly upon the development of objective strategies for the isolation 
and characterization of such novel and rare microorganisms.  
Within marine environments, taxonomically diverse bacterial groups exhibit unique physiological 
and structural characteristics that enable them to survive in extremes of pressure, salinity and 
temperature, with the potential production of novel secondary metabolites not observed in terrestrial 
microorganisms [13, 18, 49]. Much interest on the screening of marine and aquatic microorganisms is 
focused on screening sediment derived microorganisms [9, 14, 21, 32, 34, 47], and also on those that 
form highly specific symbiotic associations with marine plants and animals in response to the scarcity 
of nutrients in aquatic and marine environments, and thus produce compounds for defense and 
competition [36, 70]. 
Since the discovery of the antibiotic streptomycin in 1943 [57], actinomycetes have generally been 
the target of pharmaceutical research due to their ability to produce a diverse array of bioactive 
compounds [16, 28]. In particular, those actinomycetes of the family Micromonosporaceae, have been 
a rich source of bioactive molecules and the most prolific producers of anti-infective agents [42] 
behind the members of the genus Streptomyces from the production of antibiotic complex gentamicin 
in 1963 onwards [59] with a continuous stream of bioactive compounds including antibacterial and 
anti-tumor agents [30, 52]. Micromonosporae isolated from marine environments reportedly possess 
the highest rate of anti-tumor activity of the marine actinomycetes [70] including the recently detected 
cyctotoxic salinosporamides from Salinispora [61] and rifamycin from Micromonospora species [32] 
isolated from sediments.  
Micromonosporae are frequent inhabitants of aquatic habitats worldwide where it is claimed they 
participate in the decomposition of cellulose, chitin and lignin [14, 24]. They have been isolated from 
water samples from streams, rivers and lakes, from lake mud, river sediments, beach sands, littoral 
sediments and deep marine sediments [14, 23, 33]. Micromonosporae have been found to be the 
dominant actinomycetes group in a range of aquatic environments, particularly in the deeper mud 
layers as well as in deep sea sediments [46, 51].  
In Australia, significant efforts are underway to document the microbial diversity with industrial 
importance [4, 5, 11, 36, 37, 39]. The study of microbial flora associated with aquatic habitats and the 
screening of these organisms for valuable genetic material is receiving growing attention in the search 
for structurally diverse bioactive metabolites. Southeast Queensland offers a diverse array of aquatic 
habitats from saltwater estuaries and mangrove habitats to freshwater creeks and lakes for the study of 
occurrence and distribution of antibiotic-producing actinomycetes. In particular, the previously 
unscreened sub-tropical Sunshine Coast region can thus be seen as a key environment with a diverse 
range of biological resources to initiate ecological research into the habitats of those organisms that 
produce bioactive substances [40]. 
Rusnak et al., [52] have reported the isolation of a mixture of polycyclic aromatic compounds with 
activity against Gram-positive bacteria from a gentamicin producing species of Micromonospora Mar. Drugs 2008, 6                 
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stressing once more the fascinating biosynthetic potential of the taxon members in the production of 
diverse compounds. In line with this discovery the present study has investigated the occurrence of 
bioactive compound producing micromonoporae with particular emphasis on the gentamicin 
production from aquatic samples and sediments within Sunshine Coast habitats. 
Results  
Isolation and identification of Micromonosporae 
Actinomycetes resistant to gentamicin were isolated from 20 of the 23 sediment samples collected 
at Sunshine Coast aquatic habitats on isolation media containing 1 μg/ml of gentamicin (Fig 1). Those 
sediments associated with habitat type HB-1, numerically displayed the largest populations of 
gentamicin-resistant actinomycetes, with a mean occurrence of 4.9 x 10
4.g
-1 of dried sediment. In HB-
2, HB-3, HB-4 and HB-5, gentamicin-resistant actinomycetes were isolated on average between 4.0 x 
10
2 and 1.2 x 10
3.g
-1 of dried sediment. 
Figure 1. Average abundance of gentamicin-resistant actinomycete isolates (cfu) per gram 
of dried sediment sample. 
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Micromonosporae were the predominant group of actinomycetes associated with HB-1 and HB-2, 
constituting 39.8% and 45.8% of the total gentamicin-resistant actinomycetes populations respectively. 
In HB-3 16.7% and HB-4 19.5% gentamicin-resistant micromonosporae isolates were detected. No 
micromonosporae isolates were recovered from the HB-5 (Fig 2). 
Actinomycetes resistant to gentamicin were also isolated from six of nine lily-leaf specimens collected 
in Sunshine Coast aquatic habitats, predominantly on those lily-leaf samples in which decomposition 
was evident. Overall, 191 actinomycetes were isolated from lily-leaf specimens on isolation media 
containing 1 μg/ml gentamicin. Micromonosporae isolates, detected on all four of the decomposing 
lily-leaf samples, were found with a mean occurrence of 0.3 x 10
2.g
-1 of decomposing leaf sample, 
accounting for 9.8% of isolates, with the remaining 25.6% of isolates made up of actinomycetes 
identified as other, which belonged to neither micromonosporae nor streptomycetes. 
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Figure 2. Composition of sediment derived actinomycetes associated with Sunshine Coast 
aquatic habitats. 
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In total, 75 actinomycetes from Sunshine Coast sediment and lily-leaf samples were identified as 
micromonosporae following their preliminary characterization (Fig 3). Forty-eight of these isolates 
were recovered from sediment samples on isolation medium containing 1 μg/ml of gentamicin, with a 
further 10 from lily leaf samples on this isolation medium. From those remaining isolates, five were 
isolated through preliminary sampling of sediments on isolation medium containing 5 μg/ml of 
gentamicin, and 12 without the addition of gentamicin to the isolation medium. 
Figure 3. Light microscopic view of Micromonospora isolate USC-714, indicating single 
spore structures on a stable substrate mycelium typical of this genus. 
 
 
Further molecular sequencing indicated that the isolates belonged to the family 
Micromonosporaceae (Fig 4). 
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Figure 4. Phylogenetic tree of 16S rRNA gene sequences obtained from micromonosporae 
isolates compared against sequences obtained from public databases. The scale bar 
represents 10% sequence divergence. Fischerella muscicola was used as an out-group 
(GenBank accession numbers of reference sequences are included in brackets). 
 
Testing for antimicrobial activity 
The antimicrobial activity of the isolates is shown in Table 3. All six antibiotic-producing 
Micromonospora control strains were shown to inhibit the growth of the Gram-positive test organism 
used in this study. The gentamicin-producing M. echinospora type strain (DSM 43816) was the only 
control strain shown to produce a broad spectrum of activity, capable of inhibiting the growth of both 
the Gram-positive and Gram-negative test organisms. 
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Table 3. Antibacterial activity of Micromonospora  isolates from the Sunshine Coast 
aquatic habitats. 
Original Isolation 
Media 
Number of isolates 
screened for 
antibacterial 
activity 
Antibacterial activity Percent (%) of total 
With gentamicin  59  6  10.2% 
Without gentamicin  12  6  50.0% 
Total 71  12  16.9% 
Table 4. Activity spectra of the bioactive compounds extracted from the Sunshine Coast 
Micromonospora isolates. 
Isolate no. 
Antimicrobial activity 
S. aureus  E. coli  VRE 
USC-702
 a  √  X X 
USC-703
 a  √  X X 
USC-705
 b  √  X X 
USC-706
 b  √  X X 
USC-707
 b  √  X X 
USC-708
 a  √  X X 
USC-710
 b  √  √  √ 
USC-712
 b  √  X X 
USC-713
 b  √  X X 
USC-731
 a  √  √  X 
USC-757
 a  √  X X 
USC-758
 a  √  √  √ 
√ Denotes inhibition of the growth of the test organism. 
X Denotes non-inhibition of the growth of the test organism. 
a Denotes isolates obtained from media containing gentamicin. 
b Denotes isolates recovered during preliminary sampling on isolation media without gentamicin. 
 
Only 12 of the Sunshine Coast isolates were capable of producing bioactive metabolites inhibiting 
the growth of either test organism (Table 4). Six of these antimicrobial compound producing isolates 
were recovered from the medium to which gentamicin had been added, with the remaining six isolates 
recovered during preliminary sampling from the medium without the gentamicin. 
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Only three isolates (USC-710, USC-731 and USC-758) displayed a broad spectrum of activity, 
inhibiting the growth of both the Gram-positive and Gram-negative test organisms, while only two 
isolates (USC-710 and USC-758) were also found to inhibit the growth of the VRE strain (Table 4). 
USC-710 and USC-731 were isolated from HB-1 and the USC-758 was isolated from HB-4. 
Chemical characterization of the bioactive compounds produced by the isolates  
Antibacterial activity was persistent within the primary and secondary crude extracts deriving from 
the isolates USC-710, USC-731, USC-758 and the gentamicin-producing type strain M. echinospora 
(DSM 43816). The observed inhibition was found to be greatest in the primary extracts, compared to 
those produced from the secondary extracts. 
Reversed-phase HPLC analyses of derivatized gentamicin-sulfate and the derivatizing reagent 
(OPA/N-acetyl-L-cysteine) alone, revealed fluorescent isoindole derivatives of gentamicin with 
OPA/N-acetyl-L-cysteine, separated into three fractions (A, B and C with retention times of 8.4, 10.9 
and 14.5 minutes, respectively) that absorbed radiation at 230 nm and fluoresced at 455 nm (Figure 5). 
Absorbance at 230 nm and fluorescence at 455 nm is characteristic of isoindole derivatives, proving 
that the parent compound contained primary amine functions. 
Figure 5. HPLC plot of derivatized gentamicin sulfate standard indicating gentamicin 
fractions (A, B and C) eluting at 8.4, 10.9 and 14.5 minutes: (a) absorption: 230 nm; (b) 
fluorescence: 455 nm. 
 
 
When the HPLC traces of the derivatized crude and the non-derivatized crude extracts from DSM 
43816 were compared with the gentamicin-sulfate standard, no corresponding absorbing and 
fluorescing peak was found within the non-derivatized sample. The derivatize extract of DSM 43816 
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displayed a new fluorescing peak at 11.2 minutes. This result indicated that gentamicin-like 
compounds were present in the crude extract obtained from the type strain (Figure 6). Whereas the 
HPLC analyses of the derivatized crude extracts from isolates USC-710, USC-731 and USC-758, 
revealed that no corresponding absorbing or fluorescing peaks were present in the region of the 
gentamicin standard. This indicates that none of the Sunshine Coast isolates were found to produce 
detectable levels of gentamicin or related primary amine antibiotic structures following HPLC 
analyses. The antibacterial activity associated with the crude extracts of these isolates is therefore not 
due to the activity of gentamicin or gentamicin-related compounds. 
Figure 6. HPLC plot of DSM 43816 crude extract indicating peak eluting at 11.2 minutes: 
(a) absorption: 230 nm; (b) fluorescence: 455 nm. 
 
 
Discussion 
Following the application of the highly selective isolation techniques including selecting for 
gentamicin-resistance, micromonosporae were found to be the dominant actinomycete genus within 
Sunshine Coast aquatic sediments. Micromonosporae isolates were recovered from sediment samples 
collected at both marine and freshwater habitats, including littoral sands, river banks, creek beds and 
lake mud with the vast majority of micromonosporae and other actinomycetes isolates being obtained 
from mangrove mud habitats. These findings support the observations made by previous research 
towards the presence of bioactive compound producing actinomycetes [2, 32] in mangrove habitats 
which are highly productive marine ecosystems due to the high input of organic materials in the form 
of detritus. Through the breakdown of detritus materials, mangrove habitats support an abundant and 
diverse variety of organisms [1]. Micromonosporae isolates were reported to decompose complex 
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organic compounds, such as cellulose, lignin and chitin that are not readily decomposed by the 
majority of aerobic bacteria and thus tend to accumulate in sediments [14]. Accordingly, 
micromonosporae found to be predominantly associated with mangrove mud sediments in this study 
can be seen as important components of benthic microbial communities within mangrove habitats, 
active in the degradation of complex organic materials.  
Isolation of actinomycetes from decomposing lily-leaf samples revealed the predominance of 
actinomycetes including micromonosporae. These findings might provide further evidence towards the 
contribution of actinomycetes to the degradation of detritus and agree with the observation made by 
Goodfellow and Williams [24] in that micromonosporae and other genera of actinomycetes play an 
ecologically important role in the decomposition of plant materials, including cellulose and lignin, in 
aquatic ecosystems. The isolation procedures undertaken from leaf specimens subject to 
decomposition yielded greater densities of actinomycetes than those specimens without signs of 
decomposition. Wohl and McArthur [69] also reported that micromonosporae  were found to be 
common isolates from dead leaf-tissues. 
In comparison to mangrove mud sediments, those remaining benthic communities associated with 
littoral sand sediments, freshwater creek and lake habitats, yielded relatively low populations of 
gentamicin-resistant actinomycetes. In the analyses of benthic actinomycetes in freshwater lake 
sediments of the Sunshine Coast, micromonosporae were detected at a maximum concentration of 2.0 
x 10
3.g
-1 of dried sediment. These findings also support the results of other researchers who reported 
correlations between the numbers of actinomycetes and organic matter content of that aquatic habitat 
[10, 14, 68]. 
Actinomycetes, in particular micromonosporae isolates are reported to be common inhabitants of 
lake habitats, especially in lake sediments [14], with the distribution and numbers of actinomycetes in 
lake habitats often reflecting the productivity status of the lake [35]. The comparatively low numbers 
of micromonosporae in Sunshine Coast freshwater habitats and littoral sand sediments may therefore 
be related to the low organic nutrient levels typical of these environments, compared to high nutrient 
habitats, such as those of mangrove mud.  
Gause  et al. [19] demonstrated that antibiotic-producing actinomycetes possess resistance 
determinants to self-produced antibiotics. Other researchers have reported a correlation between self-
produced antibiotic resistance and the antibiotic production [17, 29, 31]. Consequently, gentamicin 
resistance has been used in rapid screening strategies for the isolation of antibiotic producing 
micromonosporae [5, 8, 31]. Although in this study micromonosporae isolated from the agar plates 
incorporated with gentamicin were not found to have an increased ability of producing diffusible 
bioactive metabolites compared to those isolated from the agar plates without gentamicin, the most 
bioactive isolates USC-731 and USC-758 were still isolated from the plates with gentamicin 1 μg/ml 
and 5 μg/ml respectively.  
Isolation of bioactive compound producing micromonosporae in the Sunshine Coast aquatic 
habitats might be deriving from ecological functions of the microorganisms [64] rather than their 
resistance to gentamicin. According to Williams [62], antibiotic production is often associated with 
sites of high nutrient content as in areas rich in decaying organic matter, with antibiotic production 
evolving in response to selective pressures created through increased competition. Long and Azam 
[43] found in their study on antagonistic interactions among marine pelagic bacteria that a greater Mar. Drugs 2008, 6                 
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ability to chemically inhibit their free-living counterparts was a characteristic of particle attached 
bacteria. They suggested that the production of inhibitory metabolites play an important ecological 
role in deterring free-living bacterial competitors, aiding particle attached bacteria during competition 
for resources and involvement in biogeochemical cycling. This might relate to increased biological 
activities among micromonosporae associated with detritus in aquatic environments as well as with 
sediments. 
Findings indicate that if target directed and highly selective isolation techniques are used, bioactive 
micromonosporae and other actinomycetes could be detected in mangrove and organic rich sediments.  
Such efforts can then contribute towards the national efforts in establishing information on the 
distribution of bioactive actinomycetes in Australian habitats [39, 40]. 
Experimental Section 
Sampling Sites 
A total of 23 aquatic sediment samples and nine lily-leaf samples were collected from 26 aquatic 
habitats around the Sunshine Coast, Queensland for the selective isolation of actinomycetes. Sediment 
sampling was conducted into sterile Petri-plates from the upper 20 mm of surface sediment, at water 
depths ranging down to 200 mm. Sample types were grouped into one of the six classifications, 
specified according to observations of marine or freshwater environment and sediment composition 
(Table 1). 
 
Selective Isolation of Micromonosporae 
Combinations of selective pressures were applied to the samples to deselect common bacterial taxa 
on isolation plates. Air-dried (ambient room temperature for 14 days), ground and sieved sediment 
samples [27] were subjected to dry heat treatment at 55°C for 30 minutes (modified from Rowbotham 
and Cross [51]). Following the heat treatment, the sediment samples (2 g) were further microwave 
irradiated at 80 watts for 30 seconds [12]. Irradiated sediment samples were subjected to a 10 fold 
dilution series and aliquots (0.5 ml) from selected dilutions spread plated in triplicates onto the surface 
of the isolation media. 
For the isolation of micromonosporae from lily-leaf samples surface sterilized and chopped leaf 
portions were placed into sterile water (9.0 ml) and shaken in a Flask-Shaker SF-1 (Stuart Scientific, 
UK) for 20 minutes (modified from Shimizu et al. [54]). Leaf suspensions were further subjected to 
sonication (modified from Wohl and McArthur [69]) for 1 minute in a sonicated water bath (Soniclean 
160HT, Soniclean Pty. Ltd.). Sonicated leaf samples were further wet heat treated at 55°C for 60 min 
in a water bath (modified from Rowbotham and Cross [51]). A 10 fold dilution series was prepared of 
the heat treated samples in sterile water and aliquots (0.5 ml) from selected dilutions were spread 
plated in triplicates onto the surface of the isolation media. 
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Table 1. Sunshine Coast aquatic sampling locations and habitat types. 
 
Sample Locations   Habitat types  Habitat Descriptive Image 
Petrie Ck, McDonald Rd, Diddillibah (S1) 
Paynter Ck, Diddillibah Rd, Diddillibah (S2) 
Maroochy R, River Store Rd, Maroochy (S3) 
 
HB-1 
Mangrove mud 
sediments 
derived from the 
Maroochy River 
or tributaries 
 
Maroochy R, Muller Park, Bli Bli (S4) 
Maroochy R, Oysterbank Rd, Bli Bli (S5) 
Maroochy R, Nojoor Rd, Mudjimba (S6) 
Eudlo Ck, Fishermans Rd, Maroochydore (S7) 
HB-2 
Sand sediments 
derived from the 
Maroochy River 
or tributaries 
 
Stumers Ck, David Low Way, Coolum (S19) 
Coondibah Ck, Flinders St, Currumundi (S20) 
Currumundi Lake, Noel Burns Park, Currumundi (S21) 
Mooloolah R, Marra Ct, Mountain Creek (S22) 
HB-3 
Marine sand 
sediments not 
derived from the 
Maroochy River 
or tributaries 
 
Lillyponds, Delicia Rd, Mapleton (S11) 
Tesch Park, Coral St, Maleny (S16) 
Ewen Maddock Dam, Glass House Mountains Rd, Landsborough 
(S17) 
Lake Macdonald, Noosa Shire Botanical Gardens, Pomona (S18) 
Wetland adjacent to David Low Way, Marcoola (S23) 
HB-4 
Fine, silty 
sediment from 
freshwater 
habitats 
 
Obi Obi Creek Crossing no. 2, Obi Obi Rd, Kidaman Creek (S12) 
Little Yabba Ck, Little Yabba Creek Picnic Area, Conondale-
Kenilworth Rd, Kenilworth (S13) 
Boolumba Ck, Dayuse Area - Area 2, Booloomba Creek Rd, 
Kenilworth (S14) 
Mary River, Maleny-Kenilworth Rd, Conondale (S15) 
HB-5 
Coarse grained 
sediment from 
freshwater 
habitats 
Wappa Dam, Wappa Dam Rd, Kiamba (L24) 
Wetland adjacent to David Low Way, Marcoola (L25) 
Hyatt Regency Lakes, David Low Way, Coolum (L26) 
Nelson Park Lakes, Alexandra Headland (L27) 
Lake Macdonald, Noosa Shire Botanical Gardens, Pomona (S18) 
Ewen Maddock Dam, Glass House Mountains Rd, Landsborough 
(S17) 
Wetland adjacent to David Low Way, Marcoola (S23) 
HB-6 
Lily-leaf 
samples from 
freshwater 
habitats Mar. Drugs 2008, 6                 
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The medium used for the isolation and enumeration of the gentamicin-producing micromonosporae 
from sediment and lily-leaf samples was Gause Mineral agar #1 [12], supplemented with the antifungal 
agents cycloheximide (50 μg/ml) and nystatin (50 μg/ml) [63]. Media was also supplemented with 
gentamicin-sulphate (1 μg/ml) to select for actinomycetes with resistance to gentamicin [19]. As a 
control treatment, isolation plates without gentamicin-sulphate were also used to test whether the 
incorporation of the antibiotic gentamicin (5 μg/ml) would affect the growth of the targeted taxon.  
The isolation plates were inoculated with selected dilutions and air dried in a biological safety 
cabinet for 20 min [56]. The inoculated plates were incubated at 28°C for 28 days [65], following 
which the colonies were enumerated on the basis of the morphological characteristics of the previously 
described actinomycete taxa [22]. 
Identification of the isolates 
Purified isolates onto oatmeal agar [66] were further tentatively identified according to their 
characteristic morphology of sporulating structures and spore arrangements under light microscope 
using the cover slip technique [15]. Purified isolates were stored in 20% glycerol suspension placed 
into 2 ml cryogenic vials (In vitro Technologies Pty. Ltd., Australia) and kept at -20°C [60]. 
Isolates were further characterized using molecular sequencing [58] methods. For molecular 
characterization the PCR products were sequenced at the Australian Genome Research Facility, 
Brisbane. Once the sequence information is received the ARB program [45] was used for sequence 
alignment and phylogenetic analyses as described previously [50]. Sequences that were closely related 
to isolate 16S rRNA gene sequences were identified in ARB and were used in the analysis. 
Phylogenetic trees were calculated using evolutionary distance (Jukes and Cantor model), maximum 
parsimony (ARB and DNAPARS) and maximum likelihood (ARB and FASTDNAML) analyses of the 
aligned near full-length sequences [44]. Tree topologies generated using the three methods were 
compared and a tree representative of the overall consensus tree was selected. The phylogenetic tree 
presented is based on the evolutionary distance analysis.  
Testing for antimicrobial activity 
Seventy one selected micromonosporae isolates were tested for their antimicrobial activities. Fifty 
nine of these isolates were recovered from isolation medium incorporated with gentamicin and the 
remaining 12 were the isolates from the medium without gentamicin incorporation.  
Antibiotic producing type strains obtained from the DSMZ, Germany were used as control 
organisms (Table 2). Laboratory strains of Gram-positive (Staphylococcus aureus, penicillin sensitive, 
(Strain code: NA-1) and Gram-negative (Escherichia coli (Strain code: Hb 101)) and a Vancomycin 
resistant Entrococcus strain (VRE, clinical isolate obtained from a local hospital) were used to test the 
antimicrobial activity of the micromonosporae isolates. 
Agar plugs were removed with a 5 mm diameter corer from 14 day old growing cultures of the 
actinomycetes on oatmeal agar medium. The surface growth on agar plugs was removed with a sterile 
scalpel blade, to obtain only the diffused microbial metabolites in the agar plugs. The agar plugs were 
inverted and placed onto nutrient agar plates inoculated with the test organism. The plates were then 
incubated at 37°C for 24 hours. Following incubation, antimicrobial activity was indicated by the Mar. Drugs 2008, 6                 
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formation of an inhibition zone surrounding the agar plug, which may provide an indication of diffused 
antimicrobial metabolites produced by the growing actinomycetes culture. The absence of an 
inhibition zone indicated a negative result for the production of diffusible metabolite into the solid 
growth medium. 
Table 2. Micromonospora type strains obtained from the DSMZ (German Collection of 
Microorganisms and Cell Cultures, Braunschweig, Germany, http://www.dsmz.de/) 
DSM No.  Organism 
Antibiotic 
produced 
Isolated from 
DSM 803  M. rosaria
   Rosaramycin Soil 
DSM 43168  M. carbonacea
   Everninomicins   Soil 
DSM 43171  M. halophytica
   Halomycin   Salt pool 
DSM 43816  M. echinospora
   Gentamicin Soil 
DSM 43817  M. pallida
   Gentamicin   Soil 
DSM 43818  M. nigra
   Halomycin Salt  pool 
DSM 43868  M. olivasterospora
   Fortamicin B  Soil, paddy field 
Chemical characterization of the bioactive compounds 
Gentamicin is a basic, polar, broad-spectrum, antibiotic complex belonging to the aminoglycoside 
family of antibiotics, which contains primary amine functions that can be separated and analyzed by a 
High Performance Liquid Chromatography (HPLC) when appropriately derivatized [53]. Bioactive 
compounds produced by the micromonosporae isolates as well as the diffused antimicrobial 
metabolites of the gentamicin-producing M. echinospora type strain (DSM 43816) were analyzed 
using a HPLC (Perkin Elmer Series 200) for the presence of gentamicin-like compounds.  
Ten selected isolates with displayed antimicrobial activity during the preliminary tests and the 
gentamicin-producing  M. echinospora type strain (DSM 43816) were grown on oatmeal agar. 
Inoculated plates were incubated at 28°C for 14 days, allowing for the diffusion of antimicrobial 
products into the agar medium by the microorganisms (adapted from Kurtböke et al., [41]). Following 
incubation, the agar plates of each isolate were blended to form an agar mash. The antimicrobial 
metabolites were extracted by suspending the agar mash in 500 ml of methanol (MeOH) with 1 ml of 
acetic acid and keeping the blend overnight in a fume cupboard. The MeOH solvent containing 
diffused bioactive compounds were then separated from the agar mash by vacuum filtration. Excess 
MeOH and acetic acid was concentrated on a BÜCHI Rotavapor (Model R-205) under reduced 
pressure. The remaining aqueous filtrate formed the primary crude extract. Remaining agar mash was 
again blended and re-suspended in 200 ml of MeOH overnight, with a secondary aqueous crude extract 
obtained following filtration and evaporation. Mar. Drugs 2008, 6                 
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Testing of crude extracts for retention of antimicrobial activity 
Crude extracts were tested for the retention of antimicrobial activity following extraction from the 
agar mash. The aqueous extracts were dissolved onto antibiotic susceptibility test disks (OXOID, 
Australia) and later the test disk was dried in a laminar flow cabinet until the solvent evaporated. Dried 
test disks were placed along with a gentamicin test disk (OXOID Australia, CN 30) and dried agar 
mash segments (as controls if the compound were not to be extracted and retained in the agar mash) 
onto nutrient agar plates inoculated with the S. aureus, E. coli and VRE test strains. These plates were 
incubated at 37°C for 24 hours and inhibition zones were recorded. 
HPLC analysis of crude extracts 
Detection of gentamicin and gentamicin-related fractions in the crude extracts was undertaken by 
OPA/N-acetyl-L-cysteine derivatization and HPLC analysis. OPA/N-acetyl-L-cysteine forms isoindole 
derivatives of gentamicin which are UV absorbing at 230 nm and fluorescent at 455 nm [56]. The 
derivatised gentamicin-like compounds were separated by reverse phase HPLC and analyzed 
simultaneously at 230 nm and 455 nm. When derivatized with an OPA-N-acetyl-L-cysteine reagent, 
the derivatisation reagent yield is detectable by a corresponding absorbing and displayed fluorescence 
through HPLC analysis. The eluted derivatives (if any) were compared against those obtained 
following HPLC analysis of gentamicin-sulphate standard (Sigma-Aldrich G4793) 
The derivatizing reagent was prepared by dissolving 100 mg o-phthaldehyde (OPA) and 160 mg N-
acetyl-L-cysteine in 4.5 ml MeOH, with 1.0 ml of 0.5 M sodium borate (pH 9.5) added to the 
suspension. The OPA reagent was stored in the dark at -20°C for a period not exceeding one week. 
The primary amine functions were derivatized by filtering 40 μl of the crude extract into a 2 ml amber 
vial into which 60 μl of the OPA reagent samples were added. The suspension was placed at ambient 
temperature in the dark for four minutes to allow for the reaction to occur. 
Gentamicin derivatives were detected using a Perkin Elmer HPLC system, series 200-pump and 
diode array detector, equipped with an Alltech Spherisorb ODS-2 reverse phase column (Cat. No. 
8736; Serial no. 92100087; length 250 mm; I.D. 4.6 mm), with a mobile phase consisting of a filtered 
1:1 0.02 M NaH2PO4/0.01 M Na2HPO4 buffer : MeOH. The mobile phase was filtered (0.45 μm nylon 
membrane) and degassed prior to use. After four minutes sample reaction time, 20 μl of the mixture 
was injected with a mobile phase flow of 0.6 ml/min and 40 minute run time. Eluting compounds were 
detected at 230 nm and 455 nm and the data analyzed using Turbochrom Navigator © software on a 
Dell OptiPlex GX110. 
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